Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®

Study Identifier
MA-RES-015-001
CT.gov Identifier
NCT02554981
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dry Eye
    • Study Drug
  • Cyclosporine 0.05% Ophthalmic Emulsion
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18 - 55 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    Inclusion: * Has Eye Symptoms when using video display terminals * Has a reported history of dry eye in both eyes. Exclusion: * Diagnosed with eye infection or active inflammation. * Has worn contact lenses within the past 7 days or anticipated use during the study. * Has used any eye drops within 2 hours. * Has had laser-assisted in situ keratomileusis (LASIK) within 12 months. * Has used Restasis® within 90 days. * Has had any eye and or/lid surgeries within 6 months. * Has had cataract surgery in either eye. * Has current punctal occlusion or anticipate a change in punctal occlusion status at any point during the study. * Is currently taking any topical ophthalmic prescriptions or over-the-counter solutions, artificial tears, gels or lid scrubs that cannot be discontinued for the trial duration. * Use of medication known to cause ocular drying that is not on a stable dose for at least 30 days.

    Protocol Summary

    This study will evaluate the efficacy of Restasis® in participants with dry eye disease who engage in electronic visual tasking.

    Study Locations

    Location
    Status
    Location
    Andover Eye Associates, Inc
    Andover, Massachusetts, United States, 01810
    Status
    Not applicable
    Location
    Total Eye Care, PA
    Memphis, Tennessee, United States, 38119
    Status
    Not applicable